167 related articles for article (PubMed ID: 6285388)
21. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
[TBL] [Abstract][Full Text] [Related]
22. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
Catalano L; Fontana R; Scarpato N; Picardi M; Rocco S; Rotoli B
Haematologica; 1997; 82(1):71-2. PubMed ID: 9107088
[TBL] [Abstract][Full Text] [Related]
23. The treatment of infections in granulocytopenic patients with granulocyte transfusions.
Mód A; Harsányi V; Jakschitz M; Hollán SR
Haematologia (Budap); 1977; 11(1-2):31-40. PubMed ID: 352851
[TBL] [Abstract][Full Text] [Related]
24. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
Funada H; Harada M; Yoshida T; Hattori K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
[TBL] [Abstract][Full Text] [Related]
25. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia.
Strauss RG; Connett JE; Gale RP; Bloomfield CD; Herzig GP; McCullough J; Maguire LC; Winston DJ; Ho W; Stump DC; Miller WV; Koepke JA
N Engl J Med; 1981 Sep; 305(11):597-603. PubMed ID: 6790985
[TBL] [Abstract][Full Text] [Related]
26. Pheresis techniques in marrow transplantation.
Buckner CD; Williams B
Prog Clin Biol Res; 1981; 65():81-9. PubMed ID: 7036189
[No Abstract] [Full Text] [Related]
27. Transfusion problems associated with transplantation.
Storb R; Weiden PL
Semin Hematol; 1981 Apr; 18(2):163-76. PubMed ID: 7013074
[TBL] [Abstract][Full Text] [Related]
28. Marrow transplantation for aplastic anemia and leukemia--review of results and blood product support required.
Weiden PL; Slichter SJ; Banaji M
Prog Clin Biol Res; 1978; 28():295-312. PubMed ID: 377308
[No Abstract] [Full Text] [Related]
29. Blood component therapy in bone marrow transplantation.
Brand A; Claas FH; Falkenburg JH; van Rood JJ; Eernisse JG
Semin Hematol; 1984 Apr; 21(2):141-55. PubMed ID: 6330905
[No Abstract] [Full Text] [Related]
30. High dose granulocyte substitution after bone marrow transplantation in a case of aplastic anaemia in childhood.
Pflieger H; Arnold R; Dietrich M; Goldmann SF; Niethammer D
Helv Paediatr Acta; 1977 Sep; 32(3):241-9. PubMed ID: 372143
[TBL] [Abstract][Full Text] [Related]
31. From the NIH: Study questions use of prophylactic granulocyte transfusions for patients with acute myelogenous leukemia.
JAMA; 1982 Jan; 247(1):21. PubMed ID: 7031286
[No Abstract] [Full Text] [Related]
32. An analysis of factors predisposing to chronic graft-versus-host disease.
Ringdén O; Paulin T; Lönnqvist B; Nilsson B
Exp Hematol; 1985 Nov; 13(10):1062-7. PubMed ID: 2996920
[TBL] [Abstract][Full Text] [Related]
33. [Granulocyte substitution in febrile leukemia patients with bone marrow aplasia. 1. Results of a prospective study].
Scali G; von Felten A; Fehr J; Sauter C; Gmür J
Schweiz Med Wochenschr; 1978 Oct; 108(41):1583-5. PubMed ID: 694487
[TBL] [Abstract][Full Text] [Related]
34. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.
Meyers JD; Leszczynski J; Zaia JA; Flournoy N; Newton B; Snydman DR; Wright GG; Levin MJ; Thomas ED
Ann Intern Med; 1983 Apr; 98(4):442-6. PubMed ID: 6301320
[TBL] [Abstract][Full Text] [Related]
35. Marrow transplant experience for children with severe aplastic anemia.
Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Hägglund H; Boström L; Ringdén O; Nilsson B; Remberger M
Transplant Proc; 1994 Jun; 26(3):1821-2. PubMed ID: 8030154
[No Abstract] [Full Text] [Related]
37. Leukapheresis and granulocyte transfusion.
McCullough J
Arch Pathol Lab Med; 1978 Feb; 102(2):53-6. PubMed ID: 579963
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic role of granulocyte transfusions.
DiNubile MJ
Rev Infect Dis; 1985; 7(2):232-43. PubMed ID: 3890096
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte transfusions in severe aplastic anemia: an eleven-year experience.
Quillen K; Wong E; Scheinberg P; Young NS; Walsh TJ; Wu CO; Leitman SF
Haematologica; 2009 Dec; 94(12):1661-8. PubMed ID: 19996117
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus hyperimmunoglobulin and substitution with blood products from antibody-negative donors. A pilot study in bone marrow transplant recipients.
Mahmoud HK; Beelen DW; Neumann MC; Thraenhart O; Quabeck K; Schaefer UW
Haematol Blood Transfus; 1987; 30():538-40. PubMed ID: 3040547
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
